Double-blind, randomized, placebo-controlled pilot clinical trial with gamma-band transcranial alternating current stimulation for the treatment of schizophrenia refractory auditory hallucinations

Abstract Gamma oscillations are essential for brain communication. The 40 Hz neural oscillation deficits in schizophrenia impair left frontotemporal connectivity and information communication, causing auditory hallucinations. Transcranial alternating current stimulation is thought to enhance connect...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaojuan Wang, Xiaochen Zhang, Yuan Chang, Jingmeng Liao, Shuang Liu, Dong Ming
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Translational Psychiatry
Online Access:https://doi.org/10.1038/s41398-025-03256-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571290317225984
author Xiaojuan Wang
Xiaochen Zhang
Yuan Chang
Jingmeng Liao
Shuang Liu
Dong Ming
author_facet Xiaojuan Wang
Xiaochen Zhang
Yuan Chang
Jingmeng Liao
Shuang Liu
Dong Ming
author_sort Xiaojuan Wang
collection DOAJ
description Abstract Gamma oscillations are essential for brain communication. The 40 Hz neural oscillation deficits in schizophrenia impair left frontotemporal connectivity and information communication, causing auditory hallucinations. Transcranial alternating current stimulation is thought to enhance connectivity between different brain regions by modulating brain oscillations. In this work, we applied a frontal-temporal-parietal 40 Hz-tACS stimulation strategy for treating auditory hallucinations and further explored the effect of tACS on functional connectivity of brain networks. 32 schizophrenia patients with refractory auditory hallucinations received 20daily 20-min, 40 Hz, 1 mA sessions of active or sham tACS on weekdays for 4 consecutive weeks, followed by a 2-week follow-up period without stimulation. Auditory hallucination symptom scores and 64-channel electroencephalograms were measured at baseline, week2, week4 and follow-up. For clinical symptom score, we observed a significant interaction between group and time for auditory hallucinations symptoms (F(3,90) = 26.964, p < 0.001), and subsequent analysis showed that the 40Hz-tACS group had a higher symptom reduction rate than the sham group at week4 (p = 0.036) and follow-up (p = 0.047). Multiple comparisons of corrected EEG results showed that the 40Hz-tACS group had higher functional connectivity in the right frontal to parietal (F (1,30) = 7.24, p = 0.012) and right frontal to occipital (F (1,30) = 7.98, p = 0.008) than the sham group at week4. Further, functional brain network controllability outcomes showed that the 40Hz-tACS group had increased average controllability (F (1,30) = 6.26, p = 0.018) and decreased modality controllability (F (1,30) = 6.50, p = 0.016) in the right frontal lobe compared to the sham group. Our polit study indicates that 40Hz-tACS combined with medicine may be an effective treatment for targeting symptoms specific to auditory hallucinations and altering functional connectivity and controllability at the network level.
format Article
id doaj-art-277e8ac05fde44e7a57adf911b1994d1
institution Kabale University
issn 2158-3188
language English
publishDate 2025-01-01
publisher Nature Publishing Group
record_format Article
series Translational Psychiatry
spelling doaj-art-277e8ac05fde44e7a57adf911b1994d12025-02-02T12:43:33ZengNature Publishing GroupTranslational Psychiatry2158-31882025-01-0115111010.1038/s41398-025-03256-zDouble-blind, randomized, placebo-controlled pilot clinical trial with gamma-band transcranial alternating current stimulation for the treatment of schizophrenia refractory auditory hallucinationsXiaojuan Wang0Xiaochen Zhang1Yuan Chang2Jingmeng Liao3Shuang Liu4Dong Ming5Academy of Medical Engineering and Translational Medicine, Tianjin UniversityAcademy of Medical Engineering and Translational Medicine, Tianjin UniversityAcademy of Medical Engineering and Translational Medicine, Tianjin UniversityAcademy of Medical Engineering and Translational Medicine, Tianjin UniversityAcademy of Medical Engineering and Translational Medicine, Tianjin UniversityAcademy of Medical Engineering and Translational Medicine, Tianjin UniversityAbstract Gamma oscillations are essential for brain communication. The 40 Hz neural oscillation deficits in schizophrenia impair left frontotemporal connectivity and information communication, causing auditory hallucinations. Transcranial alternating current stimulation is thought to enhance connectivity between different brain regions by modulating brain oscillations. In this work, we applied a frontal-temporal-parietal 40 Hz-tACS stimulation strategy for treating auditory hallucinations and further explored the effect of tACS on functional connectivity of brain networks. 32 schizophrenia patients with refractory auditory hallucinations received 20daily 20-min, 40 Hz, 1 mA sessions of active or sham tACS on weekdays for 4 consecutive weeks, followed by a 2-week follow-up period without stimulation. Auditory hallucination symptom scores and 64-channel electroencephalograms were measured at baseline, week2, week4 and follow-up. For clinical symptom score, we observed a significant interaction between group and time for auditory hallucinations symptoms (F(3,90) = 26.964, p < 0.001), and subsequent analysis showed that the 40Hz-tACS group had a higher symptom reduction rate than the sham group at week4 (p = 0.036) and follow-up (p = 0.047). Multiple comparisons of corrected EEG results showed that the 40Hz-tACS group had higher functional connectivity in the right frontal to parietal (F (1,30) = 7.24, p = 0.012) and right frontal to occipital (F (1,30) = 7.98, p = 0.008) than the sham group at week4. Further, functional brain network controllability outcomes showed that the 40Hz-tACS group had increased average controllability (F (1,30) = 6.26, p = 0.018) and decreased modality controllability (F (1,30) = 6.50, p = 0.016) in the right frontal lobe compared to the sham group. Our polit study indicates that 40Hz-tACS combined with medicine may be an effective treatment for targeting symptoms specific to auditory hallucinations and altering functional connectivity and controllability at the network level.https://doi.org/10.1038/s41398-025-03256-z
spellingShingle Xiaojuan Wang
Xiaochen Zhang
Yuan Chang
Jingmeng Liao
Shuang Liu
Dong Ming
Double-blind, randomized, placebo-controlled pilot clinical trial with gamma-band transcranial alternating current stimulation for the treatment of schizophrenia refractory auditory hallucinations
Translational Psychiatry
title Double-blind, randomized, placebo-controlled pilot clinical trial with gamma-band transcranial alternating current stimulation for the treatment of schizophrenia refractory auditory hallucinations
title_full Double-blind, randomized, placebo-controlled pilot clinical trial with gamma-band transcranial alternating current stimulation for the treatment of schizophrenia refractory auditory hallucinations
title_fullStr Double-blind, randomized, placebo-controlled pilot clinical trial with gamma-band transcranial alternating current stimulation for the treatment of schizophrenia refractory auditory hallucinations
title_full_unstemmed Double-blind, randomized, placebo-controlled pilot clinical trial with gamma-band transcranial alternating current stimulation for the treatment of schizophrenia refractory auditory hallucinations
title_short Double-blind, randomized, placebo-controlled pilot clinical trial with gamma-band transcranial alternating current stimulation for the treatment of schizophrenia refractory auditory hallucinations
title_sort double blind randomized placebo controlled pilot clinical trial with gamma band transcranial alternating current stimulation for the treatment of schizophrenia refractory auditory hallucinations
url https://doi.org/10.1038/s41398-025-03256-z
work_keys_str_mv AT xiaojuanwang doubleblindrandomizedplacebocontrolledpilotclinicaltrialwithgammabandtranscranialalternatingcurrentstimulationforthetreatmentofschizophreniarefractoryauditoryhallucinations
AT xiaochenzhang doubleblindrandomizedplacebocontrolledpilotclinicaltrialwithgammabandtranscranialalternatingcurrentstimulationforthetreatmentofschizophreniarefractoryauditoryhallucinations
AT yuanchang doubleblindrandomizedplacebocontrolledpilotclinicaltrialwithgammabandtranscranialalternatingcurrentstimulationforthetreatmentofschizophreniarefractoryauditoryhallucinations
AT jingmengliao doubleblindrandomizedplacebocontrolledpilotclinicaltrialwithgammabandtranscranialalternatingcurrentstimulationforthetreatmentofschizophreniarefractoryauditoryhallucinations
AT shuangliu doubleblindrandomizedplacebocontrolledpilotclinicaltrialwithgammabandtranscranialalternatingcurrentstimulationforthetreatmentofschizophreniarefractoryauditoryhallucinations
AT dongming doubleblindrandomizedplacebocontrolledpilotclinicaltrialwithgammabandtranscranialalternatingcurrentstimulationforthetreatmentofschizophreniarefractoryauditoryhallucinations